Financhill
Sell
16

ITRM Quote, Financials, Valuation and Earnings

Last price:
$0.33
Seasonality move :
-20.24%
Day range:
$0.33 - $0.35
52-week range:
$0.26 - $1.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
30.80x
P/B ratio:
--
Volume:
388.2K
Avg. volume:
954.3K
1-year change:
-81.78%
Market cap:
$14.6M
Revenue:
--
EPS (TTM):
-$0.75

Earnings Data

Next earnings date for ITRM
Feb 05
2026
Most recent earnings per share
-$0.20
Missed by $0.20
(Nov 14/2025)
Consensus Estimate
--
(Nov 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ITRM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $1.4M -- -- -- --
02/05/2026 Q4 $505K -- -- -- --
11/14/2025 Q3 -- $390K -$0.20 -- --
08/05/2025 Q2 -- -- -$0.16 -- --
05/13/2025 Q1 -- -- -$0.14 -- --
02/07/2025 Q4 -- -- -$0.25 -$0.24 -$0.01
11/14/2024 Q3 -- -- -$0.30 -$0.21 -$0.09
08/14/2024 Q2 -- -- -$0.28 -$0.50 $0.22
05/13/2024 Q1 -- -- -$0.42 -$0.54 $0.12
03/28/2024 Q4 -- -- -$0.94 -$0.99 $0.05
11/14/2023 Q3 -- -- -$0.30 -$0.88 $0.58
08/11/2023 Q2 -- -- -$0.95 -$0.72 -$0.23
05/12/2023 Q1 -- -- -$0.78 -$0.71 -$0.07
03/28/2023 Q4 -- -- -$0.41 -$1.15 $0.74
11/11/2022 Q3 -- -- -$2.38 -$0.92 -$1.46
08/12/2022 Q2 -- -- -$0.55 -$0.90 $0.35
05/13/2022 Q1 -- -- -$0.02 -$0.60 $0.58
03/28/2022 Q4 -- -- -$0.30 -- --
11/12/2021 Q3 -- -- $0.28 -- --
08/13/2021 Q2 -- -- $0.60 -- --
05/14/2021 Q1 -- -- -$12.15 -- --
03/12/2021 Q4 -- -- -$4.20 -- --
11/16/2020 Q3 -- -- -$9.00 -- --
08/06/2020 Q2 -- -- -$12.00 -- --
05/14/2020 Q1 -- -- -$16.20 -- --
03/12/2020 Q4 -- -- -$23.85 -- --
11/12/2019 Q3 -- -- -$32.25 -- --
08/14/2019 Q2 -- -- -$28.95 -- --
05/14/2019 Q1 -- -- -$21.60 -- --
03/25/2019 Q4 -- -- -$17.85 -- --
11/14/2018 Q3 -- -- -$26.55 -- --
08/14/2018 Q2 -- -- -$33.30 -- --
03/31/2018 Q1 -- -- -$13.86 -- --
12/31/2017 Q4 -- -- -$18.01 -- --
09/30/2017 Q3 -- -- -$16.14 -- --
06/30/2017 Q2 -- -- -$12.40 -- --
03/31/2017 Q1 -- -- -$11.53 -- --

Iterum Therapeutics Plc Earnings Questions

  • How Much did Iterum Therapeutics Plc Generate in Revenue Last Quarter?

    Iterum Therapeutics Plc reported $390K worth of top line sales in its most recent quarter.

  • Did Iterum Therapeutics Plc Beat Earnings Last Quarter?

    Iterum Therapeutics Plc announced earnings per share of -$0.20 which represents a miss of analyst forecast a -- per share.

  • Is Iterum Therapeutics Plc Profitable?

    Iterum Therapeutics Plc reported $15K that represents $0.00 per share over the last quarter.

  • What is the Analyst Consensus for Iterum Therapeutics Plc EPS Next Year?

    Iterum Therapeutics Plc's earnings are forecast to decrease from -$1.26 per share to -$1.03 per share next year representing a decrease of -65.2%.

  • When is Iterum Therapeutics Plc's Earnings Date?

    Iterum Therapeutics Plc's next earnings date is February 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Why Did Planet Labs Stock Rally So Much?
Why Did Planet Labs Stock Rally So Much?

Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
100
ATGL alert for Jan 10

Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.

Buy
65
RGC alert for Jan 10

Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.

Sell
50
NAIL alert for Jan 10

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock